Home > News > Acid-Sensitive Nanoparticles Treat Ovarian Cancers
August 28th, 2006
Acid-Sensitive Nanoparticles Treat Ovarian Cancers
Abstract:
Mansoor Amiji, Ph.D., of Northeastern University, and Robert Langer, Ph.D., at MIT, led the team of investigators that tested the ability of biodegradable, pH-sensitive nanoparticles to safely and effectively deliver paclitaxel to rapidly growing tumors. These nanoparticles are made of several polymers, each of which contributes useful characteristics to the nanoparticle, such as water-solubility, water-insoluble drug packaging, and ability to repel proteins in blood and avoid elimination by immune system cells.
Source:
nano.cancer.gov
Bookmark:
Nanomedicine
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Announcements
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013